Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-02 11:07:49 - browse：98

Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO.

The appointment follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina’s CEO since 2016. The battle, tipped off by Illumina’s troubled acquisition of cancer diagnostics firm Grail, had involved a proxy fight staged by activist investor Carl Icahn.

During the battle, there had been speculation that Jay Flatley, deSouza’s predecessor, could return. Under Flatley, Illumina had grown from an upstart to the dominant player in a field that has proved pivotal for medical research and delivered sizable returns to investors.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Medicare Advantage enrollment grows 7.1% to 33.4 million people

WSS

Researchers tackle phage therapy hurdles for wider adoption

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Data integrity in scientific journals requires "effort" by publishers, institutions

Medicare Advantage enrollment hits roughly 33.4 million

Medicare Advantage enrollment hits roughly 33.4 million

NVIDIA and Google execs on the future of AI and drug discovery

focus

Wikipedia

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Arc Institute generative AI designs new CRISPR systems

How one medical school became remarkably diverse

Criminal prosecution for violating HIPAA: an emerging threat

The high cost of giving birth even with insurance

Opioid cravings were reduced by anti

Bright Health sells Medicare Advantage business to Molina

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Apple is now the first public company to be valued at $3 trillion

In 'major milestone,' FDA approves first cell therapy for solid tumors

entertainment

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

With measles on the rise, a personal story of a devastating disease

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

When prostate cancer spreads, where it goes matters

Readers respond to H5N1 and livestock movements, and more

Glen Campbell's doctor discusses his public struggle with Alzheimer's

knowledge

hotspot

focus

hotspot